Molly Mulligan,
Director, Business Development,
Redwire
Dr. Molly Mulligan is director of business development at Redwire’s In Space Manufacturing and Operations business unit. In this role, she supports business development efforts for the company’s biotechnology and materials science portfolio.
Prior to joining Redwire, Dr. Mulligan worked at Space Commerce Matters as the Director of Commercialization Strategies, where she led efforts in commercial allocation and commercialization strategies. In 2017, Dr. Mulligan returned to the United States and began working for the Center for the Advancement of Science in Space (CASIS). CASIS manages the US National Lab located on the International Space Station (ISS).
In 2014, Dr. Mulligan’s expertise in the area of tissue chips led her to join SpacePharma, a start-up company in Herzliya Israel, that builds hardware for research platforms based in space.
Dr. Mulligan did her post-doctoral work in Biomedical Engineering at the Technion - Israel Institute of Technology. At the Technion, Dr. Mulligan’s work focused on tissue chips, this time looking at breathing lung models. Dr. Mulligan attended the University of Massachusetts Amherst (UMass), where she earned a PhD in Mechanical Engineering in 2011, and Smith College ('05), where she double majored in Physics and Astronomy.
You can Bioprint in Space Now: Redwire’s 3D Bioprinter is Ready Aboard the ISS
Tuesday, 8 November 2022 at 10:00
Add to Calendar ▼2022-11-08 10:00:002022-11-08 11:00:00Europe/LondonYou can Bioprint in Space Now: Redwire’s 3D Bioprinter is Ready Aboard the ISSThe Space Summit 2022 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
Have you ever wondered what happens when we remove gravity from our biological processes? In low Earth orbit (LEO), 400 kilometers above our heads, is the International Space Station (ISS), an orbiting research facility that provides a proving ground for innovation and next generation technology. The ISS is open for bioprinting utilizing the unique environment of microgravity. Biological systems studied in microgravity are dominated by surface tension and diffusion rather than sedimentation and convection. In the microgravity environment on the station: cells form 3D structure without the use of a scaffolding or matrix; we can print larger 3D tissue constructs without the tissue collapsing under its own weight before strengthening; we can study the mechanisms involved in biofabrication; and much more. Learning how forces other than gravity affect the process of biofabrication can help us learn new things about our processes on Earth and allows us to find ways to minimize those forces to create new and innovative products on Earth. Redwire Corporation enables bioprinting and biofabrication in microgravity, where there are unique solutions to many problems in the laboratory and lots of room for innovation. The company has the only extrusion-based 3D bioprinter on the ISS, called the Biofabrication Facility (BFF). Redwire seeks to understand what the latest technology breakthroughs are terrestrially, so that microgravity can be used to create even more innovation in the fields of bioprinting and biofabrication. As always, the ISS is open for research from around the world, and Redwire is eager to collaborate.
Add to Calendar ▼2022-11-07 00:00:002022-11-08 00:00:00Europe/LondonThe Space Summit 2022The Space Summit 2022 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
Add to Calendar ▼2022-11-08 10:00:002022-11-08 11:00:00Europe/LondonYou can Bioprint in Space Now: Redwire’s 3D Bioprinter is Ready Aboard the ISSThe Space Summit 2022 in Boston, USABoston, USASELECTBIOenquiries@selectbiosciences.com
